Long-acting coagulation factors and methods of producing same
First Claim
1. A method of treating hemophilia A in a subject, the method comprising administering a CTP-modified Factor VII (FVII) polypeptide to said subject, wherein said CTP-modified Factor VII (FVII) polypeptide consists of a coagulation Factor VII (FVII) polypeptide and three chorionic gonadotropin carboxy terminal peptides (CTPs) attached to the carboxy terminus of said coagulation FVII polypeptide, thereby treating said hemophilia A.
1 Assignment
0 Petitions
Accused Products
Abstract
Polypeptides comprising at least one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to the carboxy terminus but not to the amino terminus of a coagulation factor and polynucleotides encoding the same are disclosed. Pharmaceutical compositions comprising the polypeptides and polynucleotides of the invention and methods of using and producing same are also disclosed.
153 Citations
21 Claims
- 1. A method of treating hemophilia A in a subject, the method comprising administering a CTP-modified Factor VII (FVII) polypeptide to said subject, wherein said CTP-modified Factor VII (FVII) polypeptide consists of a coagulation Factor VII (FVII) polypeptide and three chorionic gonadotropin carboxy terminal peptides (CTPs) attached to the carboxy terminus of said coagulation FVII polypeptide, thereby treating said hemophilia A.
- 11. A method of treating hemophilia B in a subject, the method comprising the step of administering to the subject a CTP-modified Factor IX (FIX) polypeptide, wherein the CTP-modified Factor IX (FIX) polypeptide consists of a coagulation Factor IX (FIX) polypeptide and three chorionic gonadotrophin carboxy terminal peptides (CTPs) attached to the carboxy terminus of said coagulation FIX polypeptide, thereby treating said hemophilia B in said subject.
Specification